Literature DB >> 6980894

Fractionation of Pneumocystis carinii antigens used in an enzyme-linked immunosorbent assay for antibodies and in the production of antiserum for detecting Pneumocystis carinii antigenemia.

S E Maddison, G V Hayes, M H Ivey, V C Tsang, S B Slemenda, L G Norman.   

Abstract

Cyst-rich suspensions of Pneumocystis carinii were obtained by differential and gradient centrifugation from heavily infected rat lungs. After preparation of an aqueous-soluble extract of the cyst-rich material, the insoluble residue was extracted with 8 M urea. Small amounts of infected human lung tissue and uninfected rat and human lung were processed similarly. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that both human and rat infected lung extracts contained a large protein (greater than 200,000 daltons). This component was not present in extracts of uninfected lung. In addition, an HCl-soluble extract was prepared from the cyst-rich suspension from infected rat lung. The urea-extracted antigen was most reactive in an enzyme-linked immunosorbent assay. Rabbit antiserum against the HCl-soluble antigen detected circulating antigen in patients' sera in a counterimmunoelectrophoresis assay.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980894      PMCID: PMC272248          DOI: 10.1128/jcm.15.6.1029-1035.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Pneumocystis carinii: new separation method from lung tissue.

Authors:  P D Walzer; M E Rutledge; K Yoneda; B J Stahr
Journal:  Exp Parasitol       Date:  1979-06       Impact factor: 2.011

2.  Immunodiagnosis of infection with Schistosoma mansoni: enzyme-linked immunosorbent assay for detection of antibody to circulating antigen.

Authors:  G H Kelsoe; T H Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

3.  Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate.

Authors:  D M Neville; H Glossmann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

5.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

6.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

7.  Enzyme immunoassays for parasitic diseases.

Authors:  A Bartlett; D E Bidwell
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

8.  Serological studies of actionomyces israelii by crossed immunoelectrophoresis: standard antigen-antibody system for A. israelii.

Authors:  K Holmberg; C E Nord; T Wadström
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

9.  Some observations on the serology of Pneumocystis carinii infections in the United States.

Authors:  L Norman; I G Kagan
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

10.  The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation.

Authors:  J D Meyers; L L Pifer; G E Sale; E D Thomas
Journal:  Am Rev Respir Dis       Date:  1979-12
View more
  16 in total

Review 1.  Why have Pneumocystis carinii trophozoites been ignored?

Authors:  J M Chatterton; A W Joss; M M Davidson; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

Review 2.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

3.  Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.

Authors:  K R Daly; J V Koch; N J Shire; L Levin; P D Walzer
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  Pneumocystis carinii antigen detection in rat serum and lung lavage.

Authors:  S J McNabb; D C Graves; S D Kosanke; M J Moyer; M H Ivey
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting.

Authors:  D C Graves; S J McNabb; M A Worley; T D Downs; M H Ivey
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

6.  Detection of specific antibody by enzyme-linked immunosorbent assay and antigenemia by counterimmunoelectrophoresis in humans infected with Pneumocystis carinii.

Authors:  S E Maddison; G V Hayes; S B Slemenda; L G Norman; M H Ivey
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

7.  Purification of Pneumocystis carinii trophozoites and identification of their circulating antigens.

Authors:  T Ishimaru; N Shimono; Y Sawae; Y Niho
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Development and characterization of monoclonal antibodies to Pneumocystis carinii.

Authors:  D C Graves; S J McNabb; M H Ivey; M A Worley
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.

Authors:  L L Pifer; D D Pifer; D R Woods
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

10.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.